Patents Examined by Gregory R. Hook
  • Patent number: 5223537
    Abstract: The invention is related to the field of treating gastric and duodenal disorders and more specifically to the use of certain 13,14-dihydro-prostaglandin E derivatives, especially of PGE.sub.2, which are modified to contain a ring structure in the omega chain. The invention relates also to pharmaceutical compositions containing an active amount of these derivatives.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: June 29, 1993
    Assignee: Kabi Pharmacia AB
    Inventors: Johan Stjernschantz, Bahram Resul